130 related articles for article (PubMed ID: 38387748)
1. Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo.
Paindelli C; Parietti V; Barrios S; Shepherd P; Pan T; Wang WL; Satcher RL; Logothetis CJ; Navone N; Campbell MT; Mikos AG; Dondossola E
Acta Biomater; 2024 Apr; 178():83-92. PubMed ID: 38387748
[TBL] [Abstract][Full Text] [Related]
2. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
3. An autologous humanized patient-derived xenograft (PDX) model for evaluation of nivolumab immunotherapy in renal cell cancer: a case report.
Kang Y; Armstrong AJ; Hsu DS
Stem Cell Investig; 2022; 9():8. PubMed ID: 36393918
[TBL] [Abstract][Full Text] [Related]
4. Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for
Brock RM; Beitel-White N; Coutermarsh-Ott S; Grider DJ; Lorenzo MF; Ringel-Scaia VM; Manuchehrabadi N; Martin RCG; Davalos RV; Allen IC
Front Oncol; 2020; 10():843. PubMed ID: 32528898
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
[TBL] [Abstract][Full Text] [Related]
6. 3D bioprinting of cartilaginous templates for large bone defect healing.
Pitacco P; Sadowska JM; O'Brien FJ; Kelly DJ
Acta Biomater; 2023 Jan; 156():61-74. PubMed ID: 35907556
[TBL] [Abstract][Full Text] [Related]
7. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
[TBL] [Abstract][Full Text] [Related]
8. Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro.
Paindelli C; Navone N; Logothetis CJ; Friedl P; Dondossola E
Biomaterials; 2019 Mar; 197():296-304. PubMed ID: 30682644
[TBL] [Abstract][Full Text] [Related]
9. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer.
Zhao Q; Hai B; Kelly J; Wu S; Liu F
Stem Cell Res Ther; 2021 Jan; 12(1):29. PubMed ID: 33413659
[TBL] [Abstract][Full Text] [Related]
11. A Simple Three-dimensional Hydrogel Platform Enables
Hribar KC; Wheeler CJ; Bazarov A; Varshneya K; Yamada R; Buckley P; Patil CG
Mol Cancer Ther; 2019 Mar; 18(3):718-725. PubMed ID: 30755456
[TBL] [Abstract][Full Text] [Related]
12. Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity.
La Manna F; De Menna M; Patel N; Karkampouna S; De Filippo MR; Klima I; Kloen P; Beimers L; Thalmann GN; Pelger RCM; Jacinto E; Kruithof-de Julio M
Front Oncol; 2020; 10():1012. PubMed ID: 32656088
[TBL] [Abstract][Full Text] [Related]
13. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
[TBL] [Abstract][Full Text] [Related]
14. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
15. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts.
Shokoohmand A; Ren J; Baldwin J; Atack A; Shafiee A; Theodoropoulos C; Wille ML; Tran PA; Bray LJ; Smith D; Chetty N; Pollock PM; Hutmacher DW; Clements JA; Williams ED; Bock N
Biomaterials; 2019 Nov; 220():119402. PubMed ID: 31400612
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
Clin Cancer Res; 2024 Feb; 30(4):849-864. PubMed ID: 37703185
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response.
Zhang W; van Weerden WM; de Ridder CMA; Erkens-Schulze S; Schönfeld E; Meijer TG; Kanaar R; van Gent DC; Nonnekens J
Prostate; 2019 Mar; 79(4):390-402. PubMed ID: 30520109
[TBL] [Abstract][Full Text] [Related]
18. Intervertebral disc and stem cells cocultured in biomimetic extracellular matrix stimulated by cyclic compression in perfusion bioreactor.
Tsai TL; Nelson BC; Anderson PA; Zdeblick TA; Li WJ
Spine J; 2014 Sep; 14(9):2127-40. PubMed ID: 24882152
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
20. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
Paez-Ribes M; Man S; Xu P; Kerbel RS
PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]